Since 2006, Akron Bio has emerged as a prominent contract manufacturer within the pharmaceutical sector, specializing in ancillary materials for the cell and gene therapy industry. Recognizing the pivotal role of high-quality, meticulously documented ancillary materials in advancing life-saving therapies, Akron Bio has been at the forefront of innovation. From pioneering the development of shelf-stable liquid cytokines to leveraging virus-inactivated plasma for superior consistency, safety, and performance in plasma-derived products, the company has consistently prioritized excellence. Recent investments in a cutting-edge plasmid DNA manufacturing facility further underscore Akron Bio’s commitment
Since 2006, Akron Bio has emerged as a prominent contract manufacturer within the pharmaceutical sector, specializing in ancillary materials for the cell and gene therapy industry. Recognizing the pivotal role of high-quality, meticulously documented ancillary materials in advancing life-saving therapies, Akron Bio has been at the forefront of innovation. From pioneering the development of shelf-stable liquid cytokines to leveraging virus-inactivated plasma for superior consistency, safety, and performance in plasma-derived products, the company has consistently prioritized excellence. Recent investments in a cutting-edge plasmid DNA manufacturing facility further underscore Akron Bio’s commitment to addressing industry bottlenecks with top-tier solutions for both ex vivo and in vivo applications. Bolstered by a team of industry leaders and a distinguished scientific advisory board, Akron Bio stands at the forefront of advancing medicine. At its essence, the company’s mission revolves around people: from its dedicated staff to collaborative customers and the patients benefiting from their groundbreaking work. With a comprehensive portfolio of cytokines, plasma-derived products, custom development and manufacturing services, along with unparalleled technical expertise and customer support, Akron Bio is truly powering the future of medicine.
